Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Chromosome 17 deletion × Cytarabine × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 52 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Burkitt Lymphoma 13 Myelodysplastic Syndromes 12 Leukemia, Biphenotypic, Acute 11 Leukemia 7 Recurrence 6 Lymphoma, Mantle-Cell 6 Lymphoma 5 Leukemia, Myelomonocytic, Chronic 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3 Myeloproliferative Disorders 3 Lymphoma, Large B-Cell, Diffuse 3 Neoplasm, Residual 2 Lymphoma, B-Cell 2 Leukemia, Myelomonocytic, Juvenile 2 Hematologic Neoplasms 2 Blastic Plasmacytoid Dendritic Cell Neoplasm 2 Vasculitis, Central Nervous System 1 Stiff-Person Syndrome 1 Sarcoma, Myeloid 1 Rasmussen subacute encephalitis 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Philadelphia Chromosome 1 Opsoclonus-Myoclonus Syndrome 1 Neuromyelitis Optica 1 Neoplasms 1 Neoplasm Metastasis 1 Myelodysplastic-Myeloproliferative Diseases 1

Interventions

venetoclax 1 pomalidomide 1 pembrolizumab 1 ibrutinib 1 fludarabine phosphate 1 fludarabine 1 acalabrutinib 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡